The CIDP market is witnessing steady growth, driven by increased diagnosis rates, improved awareness among healthcare providers, and advancements in immunotherapy. Innovations in biologics and early intervention strategies are transforming treatment outcomes worldwide. https://www.marketresearchfuture.com/reports/chronic-inflammatory-demyelinating-polyneuropathy-market-6947